Ex-pharma professional will lead DNB’s new biotech fund

DNB Asset Management is launching a new biotech fund later in April, despite the current uncertainty surrounding financial markets. Benedicte Bakke, who has spent most of her career in pharma, will be managing the fund. She tells AMWatch how a dentist ended up in asset management.

Benedicte Bakke has previously worked at Novartis and Pfizer. Photo: PR / DNB Asset Management

Log in to read our articles

Welcome to AMWatch. A part of our content is exclusive and reserved for our users.

Try AMWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles

amwatch trial

Latest news


See all

See all

Latest news from FinansWatch (dk)

Latest news from EnergyWatch

Latest news from ShippingWatch